drugset / Trial / NCT04383236

Probiotic Lozenges for Treatment of Recurrent Aphthous Stomatitis

NCT04383236

Completed 120 enrolled Reham Lotfy Aggour
RandomizedParallel-groupSingle-blindTreatment

Summary

The application of host-modulating bacteria for therapeutic purposes is one of the strongest emerging fields. Probiotics are live microorganisms, which, when administered in an adequate amount, confer a health benefit on the host The study aimed to explore the effectiveness of probiotics in the treatment of the common ulcerative condition; minor recurrent aphthous stomatitis (RAS). We included sixty adult (group A) and 60 children patients (group B) with diagnosis of minor RAS . Both groups were divided into two subgroups, AI and BI (test subgroups ) and AII and BII (control subgroups). For test subgroups, probiotic lozenges were consecutively administered twice daily, for five days. The size and pain level of ulcers were recorded on treatment days 0, 3 and 5. The outbreak frequency of RAS within 6 months was investigated for all subgroups.

Timeline

Start
2016-12-01
Primary completion
2018-10-20
Completion
2019-04-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cetylpyridinium Small molecule Topical
Comparator Lidocaine HCI Unknown Topical
Subject Probiotics Other / unclassified Topical

Indications